Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Recurrent hypoglycemia inhibits the counterregulatory response by suppressing adrenal activity
Yunbing Ma, … , Manqi Wang, Matthew D. Whim
Yunbing Ma, … , Manqi Wang, Matthew D. Whim
Published August 6, 2018
Citation Information: J Clin Invest. 2018;128(9):3866-3871. https://doi.org/10.1172/JCI91921.
View: Text | PDF
Concise Communication Neuroscience Article has an altmetric score of 11

Recurrent hypoglycemia inhibits the counterregulatory response by suppressing adrenal activity

  • Text
  • PDF
Abstract

Hypoglycemia activates the counterregulatory response (CRR), a neural-endocrine reflex that restores euglycemia. Although effective if occasionally activated, repeated induction of the CRR leads to a decline in responsiveness and prolonged exposure to hypoglycemia. The mechanism underlying this impairment is not known. We found that the reduction in epinephrine release that characterizes a suppressed CRR involves a long-lasting form of sympatho-adrenal synaptic plasticity. Using optogenetically evoked catecholamine release, we show that recurrent hypoglycemia reduced the secretory capacity of mouse adrenal chromaffin cells. Single activation of the CRR increased the adrenal levels of tyrosine hydroxylase (TH), the rate-limiting enzyme for catecholamine synthesis, but this was prevented by repeated activation. In contrast, the level of neuropeptide Y (NPY), an adrenal cotransmitter, remained elevated after recurrent hypoglycemia. Inhibition of NPY or Y1 signaling, either transgenically or pharmacologically, prevented the attenuation of both TH expression and epinephrine release. These results indicate that impairment of the CRR involves suppressed activity at the adrenal level. Interfering with the peripheral NPY–dependent negative feedback loop may provide a way to avoid the pathophysiological consequences of recurrent hypoglycemia which are common in the diabetic state.

Authors

Yunbing Ma, Qian Wang, Debria Joe, Manqi Wang, Matthew D. Whim

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2019 2018 Total
Citations: 1 3 3 2 2 4 1 16
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (16)

Title and authors Publication Year
Mouse Adrenal Macrophages Are Associated with Pre- and Postsynaptic Neuronal Elements and Respond to Multiple Neuromodulators
Whim MD
eNeuro 2025
Role of the Adrenal Medulla in Hypoglycaemia-Associated Autonomic Failure-A Diabetic Perspective.
Senthilkumaran M, Koch C, Herselman MF, Bobrovskaya L
Metabolites 2024
Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice
Jin FX, Wang Y, Li MN, Li RJ, Guo JT
World Journal of Diabetes 2024
Role of intestinal glucagon-like peptide-1 in impaired counter-regulatory responses to hypoglycemia
Dodamani MH, Hatwal J, Batta A
World Journal of Diabetes 2024
Synaptotagmin-7 facilitates acetylcholine release in splanchnic nerve-chromaffin cell synapses during nerve activity.
Caballero-Florán RN, Bendahmane M, Gupta JP, Chen X, Wu X, Morales A, Anantharam A, Jenkins PM
Neuroscience Letters 2023
Automated Insulin Delivery for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes with Hypoglycemia Unawareness.
Flatt AJ, Peleckis AJ, Dalton-Bakes C, Nguyen HL, Ilany S, Matus A, Malone SK, Goel N, Jang S, Weimer J, Lee I, Rickels MR
Diabetes Technology & Therapeutics 2023
Ghrelin does not impact the blunted counterregulatory response to recurrent hypoglycemia in mice
Shankar K, Varshney S, Gupta D, Mani BK, Osborne-Lawrence S, Metzger NP, Richard CP, Zigman JM
Frontiers in Endocrinology 2023
Evaluation of Clinical Metrics for Identifying Defective Physiologic Responses to Hypoglycemia in Long-Standing Type 1 Diabetes
Flatt AJ, Chen E, Peleckis AJ, Dalton-Bakes C, Nguyen HL, Collins HW, Millar JS, Gallop RJ, Rickels MR
Diabetes Technology & Therapeutics 2022
Impaired Awareness of Hypoglycemia in Type 1 Diabetes: A Report of An NIDDK Workshop in October 2021
Seaquist ER, Teff K, Heller SR
Diabetes care 2022
Slow but Steady—The Responsiveness of Sympathoadrenal System to a Hypoglycemic Challenge in Ketogenic Diet-Fed Rats
PE Nedoboy, M Cohen, MM Farnham
Nutrients 2021
A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study
SR Heller, MS Geybels, A Iqbal, L Liu, L Wagner, E Chow
Diabetologia 2021
Integrating the inputs that shape pancreatic islet hormone release
GM Noguchi, MO Huising
Nature metabolism 2019
Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia
S Stanley, A Moheet, ER Seaquist
Endocrine reviews 2019
Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia
ZM Kakall, MM Kavurma, EM Cohen, PR Howe, PE Nedoboy, PM Pilowsky
American journal of physiology. Endocrinology and metabolism 2019
USE OF A CONTINUOUS GLUCOSE MONITOR FOR PREOPERATIVE MONITORING AND TREATMENT OF HYPOGLYCEMIA IN A CASE OF PANCREATIC NEUROENDOCRINE TUMOR.
Lyerla RC, Bajaj A, Shrestha RT
AACE Clinical Case Reports 2019
Beyond the brain: Do peripheral mechanisms develop impaired awareness of hypoglycemia?
Elizabeth Seaquist
Journal of Clinical Investigation 2018

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 15 X users
On 1 Facebook pages
32 readers on Mendeley
See more details